article

A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects

Christoph Hatz, Frank von Sonnenburg, Daniela Casula, Maria Lattanzi, Geert Leroux-Roels (2012) VACCINE

Reference details